Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
Wei Bin Fang1,
Reneé C. Ireton1,
Guanglei Zhuang1,
Takamune Takahashi2,
Al Reynolds1,3, and
Jin Chen1,3,4,5,*
1 Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA 2 Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA 3 Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA 4 Division of Rheumatology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA 5 Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
* Author for correspondence (e-mail: jin.chen{at}vanderbilt.edu)
Accepted for publication 4 November 2007.
Abstract:
EPHA2 receptor tyrosine kinase is overexpressed in several humancancer types and promotes malignancy. However, the mechanismsby which EPHA2 promotes tumor progression are not completelyunderstood. Here we report that overexpression of a wild-typeEPHA2, but not a signaling-defective cytoplasmic truncationmutant (C), in human mammary epithelial cells weakens E-cadherin-mediatedcell-cell adhesion. Interestingly, the total level of cadherinsand the composition of the adherens junction complexes werenot affected, nor was the tyrosine phosphorylation of the cadherincomplex components changed. By contrast, RhoA GTPase activitywas significantly affected by modulating the EPHA2 activityin MCF-10A cells. Treatment with a ROCK kinase inhibitor rescuedcell-cell adhesion defects in EPHA2-overexpressing cells, whereasexpression of constitutively activated Rho disrupted adherensjunctions in C-expressing cells. EPHA2-dependent Rho activationand destabilization of adherens junctions appeared to be regulatedvia a signaling pathway involving Src kinase, low molecularweight phosphotyrosine phosphatase (LMW-PTP) and p190 RhoGAP.EPHA2 interacted with both Src and LMW-PTP, and the interactionsincreased in EPHA2-overexpressing cells. In addition, LMW-PTPphosphatase activity was elevated, and this elevation was accompaniedby a decrease in tyrosine phosphorylation of p190 RhoGAP anddestabilization of cell-cell adhesion. Expression of eithera dominant negative LMW-PTP mutant, C12S, or a wild-type p190RhoGAP rescued adhesion defects in EPHA2-overexpressing cells.Together, these data suggest that EPHA2 promotes tumor malignancythrough a mechanism involving RhoA-dependent destabilizationof adherens junctions.
Key Words: EPHA2 RhoA Adherens junction
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
John F. Foley (5 February 2008) Sci. Signal.1 (5), ec47.
[DOI: 10.1126/stke.15ec47] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Characterization of Low Molecular Weight Protein Tyrosine Phosphatase Isoforms in Human Breast Cancer Epithelial Cell Lines.
I. ALHO, L. COSTA, M. BICHO, and C. COELHO (2013)
Anticancer Res
33, 1983-1987
|Abstract »|Full Text »|PDF »
EphA2 Activation Promotes the Endothelial Cell Inflammatory Response: A Potential Role in Atherosclerosis.
S. D. Funk, A. Yurdagul Jr, P. Albert, J. G. Traylor Jr, L. Jin, J. Chen, and A. W. Orr (2012)
Arterioscler Thromb Vasc Biol
32, 686-695
|Abstract »|Full Text »|PDF »
The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1).
B. Foveau, G. Boulay, S. Pinte, C. Van Rechem, B. R. Rood, and D. Leprince (2012)
J. Biol. Chem.
287, 5366-5378
|Abstract »|Full Text »|PDF »
Eph-A2 Promotes Permeability and Inflammatory Responses to Bleomycin-Induced Lung Injury.
T. C. Carpenter, W. Schroeder, K. R. Stenmark, and E. P. Schmidt (2012) 46, 40-47
|Abstract »|Full Text »|PDF »
Ligand Targeting of EphA2 Enhances Keratinocyte Adhesion and Differentiation via Desmoglein 1.
S. Lin, K. Gordon, N. Kaplan, and S. Getsios (2010)
Mol. Biol. Cell
21, 3902-3914
|Abstract »|Full Text »|PDF »
Major Role of Epidermal Growth Factor Receptor and Src Kinases in Promoting Oxidative Stress-dependent Loss of Adhesion and Apoptosis in Epithelial Cells.
H.-L. Chan, H.-C. Chou, M. Duran, J. Gruenewald, M. D. Waterfield, A. Ridley, and J. F. Timms (2010)
J. Biol. Chem.
285, 4307-4318
|Abstract »|Full Text »|PDF »
Intercellular Junction Assembly, Dynamics, and Homeostasis.
K. J. Green, S. Getsios, S. Troyanovsky, and L.M. Godsel (2010)
Cold Spring Harb Perspect Biol
2, a000125
|Abstract »|Full Text »|PDF »
Myosin IXa Regulates Epithelial Differentiation and Its Deficiency Results in Hydrocephalus.
M. Abouhamed, K. Grobe, I. V. Leefa Chong San, S. Thelen, U. Honnert, M. S. Balda, K. Matter, and M. Bahler (2009)
Mol. Biol. Cell
20, 5074-5085
|Abstract »|Full Text »|PDF »
EphA2 in the Early Pathogenesis and Progression of Non-Small Cell Lung Cancer.
J. M. Brannan, B. Sen, B. Saigal, L. Prudkin, C. Behrens, L. Solis, W. Dong, B. N. Bekele, I. Wistuba, and F. M. Johnson (2009)
Cancer Prevention Research
2, 1039-1049
|Abstract »|Full Text »|PDF »
EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.
M. A. Cercone, W. Schroeder, S. Schomberg, and T. C. Carpenter (2009)
Am J Physiol Lung Cell Mol Physiol
297, L856-L863
|Abstract »|Full Text »|PDF »
Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis.
B. Annamalai, X. Liu, U. Gopal, and J. S. Isaacs (2009)
Mol. Cancer Res.
7, 1021-1032
|Abstract »|Full Text »|PDF »
Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells.
C. Leroy, C. Fialin, A. Sirvent, V. Simon, S. Urbach, J. Poncet, B. Robert, P. Jouin, and S. Roche (2009)
Cancer Res.
69, 2279-2286
|Abstract »|Full Text »|PDF »
Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling.
X. Huang, D. Wu, H. Jin, D. Stupack, and J. Y.J. Wang (2008)
J. Cell Biol.
183, 711-723
|Abstract »|Full Text »|PDF »